Key result
Glucose and lipid metabolism disorders drive cardiovascular injury via metabolic inflammation, lipotoxicity, metabolic memory, and gut dysbiosis, providing novel targets for precision interventions.
Design
Review
Authors
Loading...
Novel metabolic targets merit investigation in cardiometabolic disease; leaves open clinical translation pending prospective trials.
This review synthesizes the molecular mechanisms linking glucose and lipid metabolism disorders to cardiovascular disease, highlighting novel therapeutic targets such as the cGAS-STING pathway and metabolic memory.
Wu et al. (2025) conducted a review in Glucose and lipid metabolism disorders (GLMDs) and cardiovascular injuries. Glucose and lipid metabolism disorders drive cardiovascular injury via metabolic inflammation, lipotoxicity, metabolic memory, and gut dysbiosis, providing novel targets for precision interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: